Iowa Code r. 655-16.5 - Testing and drugs
(1) A licensee
may:
a. Obtain and administer drugs in
accordance with Iowa Code section
148I.4.
b. Obtain and administer the following drugs
approved by the board of nursing:
(1)
Pyridoxine (vitamin B6) IM or IV for treatment of hyperemesis;
(2) Terbutaline for cord prolapse;
and
(3) Nifedipine for
eclampsia.
c. Request
board approval to obtain and administer other drugs, not otherwise stated in
Iowa Code section 148I.4(1)
"d," consistent with the practice of certified professional
midwifery.
d. Obtain appropriate
screening and testing for clients in accordance with Iowa Code section
148I.4(1)
"c."
e. Administer
prescription drugs prescribed by a licensed health care provider to a client in
accordance with Iowa Code section
148I.4(1)
"e."
(2)
A licensee who dispenses or administers controlled substances must adhere to
657-Chapter 10.
(3) In addition to
following the standards of practice for treating a client described in rule
655-16.3 (148I), a licensee who
administers a controlled substance shall practice in accordance with the
following:
a. The client's health history will
include a personal and family substance abuse risk assessment performed by a
licensed prescribing health care provider or the documented rationale for not
performing the assessment.
b. The
client's health record must include documentation of the presence of one or
more recognized indications for the use of a controlled substance.
c. A licensee who administers any controlled
substance will maintain an active Drug Enforcement Administration (DEA)
registration and active controlled substances Act (CSA) registration when
required by the DEA and the board of pharmacy.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.